Legacy Capital Group California’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Buy
+577
New +$214K 0.07% 283
2026
Q1
– Sell
-1,228
Closed -$430K – 306
2025
Q4
$430K Buy
1,228
+11
+0.9% +$3.72K 0.1% 234
2025
Q3
$393K Buy
1,217
+468
+62% +$146K 0.1% 243
2025
Q2
$291K Sell
749
-3
-0.4% -$1.21K 0.08% 270
2025
Q1
$327K Sell
752
-4
-0.5% -$1.61K 0.11% 213
2024
Q4
$279K Buy
756
+206
+37% +$86.2K 0.09% 255
2024
Q3
$286K Sell
550
-29
-5% -$15.5K 0.1% 241
2024
Q2
$314K Sell
579
-243
-30% -$128K 0.11% 214
2024
Q1
$426K Sell
822
-10
-1% -$4.97K 0.16% 184
2023
Q4
$392K Hold
832
– – 0.15% 194
2023
Q3
$362K Sell
832
-7
-0.8% -$3.17K 0.16% 182
2023
Q2
$373K Buy
839
+25
+3% +$11.5K 0.15% 188
2023
Q1
$374K Buy
+814
New +$387K 0.18% 167

Other funds holding ELV

Legacy Capital Group California's ELV Position: Q2 2026 in Review

Legacy Capital Group California opened a new position in Elevance Health (ELV) in Q2 2026: 577 shares worth $223K. The stake represents 0.07% of the portfolio and ranks #283 among its holdings. This is a return to the name: Legacy Capital Group California previously reported a position in ELV as recently as Q4 2025.

Legacy Capital Group California first reported a position in ELV in Q1 2023 and has held it in 13 quarters since. The position peaked at $430K in Q4 2025. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Legacy Capital Group California held 577 shares of Elevance Health worth $223K as of Q2 2026.
  • Elevance Health was a new Legacy Capital Group California position in Q2 2026.
  • Elevance Health made up 0.07% of Legacy Capital Group California's portfolio in Q2 2026, its #283 holding.
  • Legacy Capital Group California first reported a position in Elevance Health in Q1 2023 and has held it in 13 quarters since.
  • Legacy Capital Group California's Elevance Health position peaked at $430K in Q4 2025.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Legacy Capital Group California's 13F filing for Q2 2026, filed 29 Jul 2026.